DEXCOM INC·4

Mar 11, 6:31 PM ET

Lawver Teri L 4

4 · DEXCOM INC · Filed Mar 11, 2024

Insider Transaction Report

Form 4
Period: 2024-03-08
Lawver Teri L
EVP Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2024-03-08+26,05371,405 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
  • [F2]Included in this number are 60,067 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 34,014 of which were granted on March 8, 2023 and shall vest through March 8, 2027.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT